留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

11C-乙酸盐心脏PET/CT成像动力学参数与成像时长关系研究

龚坦 尚斐 唐晓英 霍力 刘帅

龚坦, 尚斐, 唐晓英, 霍力, 刘帅. 11C-乙酸盐心脏PET/CT成像动力学参数与成像时长关系研究[J]. 协和医学杂志, 2023, 14(4): 758-765. doi: 10.12290/xhyxzz.2023-0121
引用本文: 龚坦, 尚斐, 唐晓英, 霍力, 刘帅. 11C-乙酸盐心脏PET/CT成像动力学参数与成像时长关系研究[J]. 协和医学杂志, 2023, 14(4): 758-765. doi: 10.12290/xhyxzz.2023-0121
GONG Tan, SHANG Fei, TANG Xiaoying, HUO Li, LIU Shuai. Relationship Between Pharmacokinetic Parameters and Imaging Duration in Dynamic 11C-Acetate Cardiac PET/CT[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 758-765. doi: 10.12290/xhyxzz.2023-0121
Citation: GONG Tan, SHANG Fei, TANG Xiaoying, HUO Li, LIU Shuai. Relationship Between Pharmacokinetic Parameters and Imaging Duration in Dynamic 11C-Acetate Cardiac PET/CT[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 758-765. doi: 10.12290/xhyxzz.2023-0121

11C-乙酸盐心脏PET/CT成像动力学参数与成像时长关系研究

doi: 10.12290/xhyxzz.2023-0121
基金项目: 

国家自然科学基金 82102136

详细信息
    通讯作者:

    刘帅, E-mail: liushuai@bit.edu.cn

  • 中图分类号: R144; R541

Relationship Between Pharmacokinetic Parameters and Imaging Duration in Dynamic 11C-Acetate Cardiac PET/CT

Funds: 

National Natural Science Foundation of China 82102136

More Information
  • 摘要:   目的  评估成像时间对动态11C-乙酸盐(11C-acetate, 11C-AC)正电子发射断层显像(positron emission tomography, PET)检查心肌组织11C-AC药代动力学参数计算结果的影响,探究临床缩短成像时间的可行性。  方法  本研究为回顾性分析,研究对象为北京协和医院接受11C-AC PET/CT心脏成像检查的46名受试者(来自于一项评估饮酒男性心肌组织和代谢特征的临床研究)。每名受试者注射740 MBq 11C-AC后均进行40 min动态11C-AC PET/CT扫描。以从左心室血池中获取11C-AC的时间活度曲线作为输入函数,40 min(53帧)图像数据拟合得到的11C-AC药代动力学参数(K1值、k2值)为参考标准,从最后一帧依次减少纳入的动态图像帧数,计算不同成像时长动态数据对应的11C-AC药代动力学参数,与参考标准进行相关性与变化趋势一致性分析并进行差异性比较,以所有心肌节段中线性回归模型拟合优度评价指标R2均大于0.9时对应的时间为最短成像时间。  结果  当成像时间≥17 min(37帧)时所有心肌节段中的11C-AC药代动力学参数K1与k2值同参考标准的相关性均较好(R2均>0.9),心肌整体平均结果中K1值、k2值与参考标准拟合的线性回归模型的回归系数分别分布于0.982~1.007和0.783~1.000。当成像时间为17 min(37帧)时,左前降支、右冠状动脉以及左回旋支灌注区域的K1值、k2值与参考标准均具有显著差异(P均<0.001),其中左前降支灌注区域相对差异(relative difference, RD)最高[K1值:(3.93±1.98)%; k2值:(13.79±6.40)%],右冠状动脉灌注区域RD最低[K1值:(2.84±1.89)%; k2值:(9.74±5.62)%]。  结论  对于饮酒或健康的男性人群,心脏11C-AC PET/CT成像检查时,缩短成像时间至17 min(37帧)可获得与标准时间相一致的示踪剂药代动力学参数,为临床优化图像采集时间提供了一定的参考依据。
    作者贡献:刘帅、尚斐、霍力负责研究方案设计;龚坦、尚斐、刘帅负责实验实施及论文撰写;尚斐、刘帅、霍力、唐晓英负责文章修订。
    利益冲突:所有作者均声明不存在利益冲突
  • 图  1  1例受试者PET动态图像及11C-AC代谢的时间活度曲线

    A.PET检查过程中5个不同时间(帧)的图像,蓝色圆形框所选为左心室血池区域;B.基于血池区域测量获得的11C-AC代谢时间活度曲线
    PET:正电子发射断层显像;11C-AC:11C-乙酸盐

    图  2  不同成像时间计算的11C-AC药代动力学参数与参考标准的相关性分析

    1~17:17个心肌节段;LAD:左前降支;RCA:右冠状动脉;LCX:左回旋支;R2:线性回归模型拟合度评价;P值:线性回归模型显著性检验; 11C-AC:同图 1

    图  3  17 min(37帧)成像时间图像数据计算的11C-AC药代动力学参数与参考标准的线性回归模型拟合结果

    11C-AC:同图 1

    图  4  17 min(37帧)成像时间图像数据拟合的17个心肌节段11C-AC药代动力学参数与参考标准的差异

    RD:相对差异;11C-AC:同图 1

    表  1  缩短成像时间获得的11C-AC药代动力学参数与参考标准拟合模型的回归系数

    成像时间
    (图像帧数)
    40 min
    (53)
    38 min
    (52)
    36 min
    (51)
    34 min
    (50)
    32 min
    (49)
    30 min
    (48)
    28 min
    (47)
    26 min
    (46)
    25 min
    (45)
    K1值回归系数 1.000 1.002 1.004 1.005 1.006 1.007 1.007 1.006 1.006
    k2值回归系数 1.000 1.000 1.000 0.998 0.994 0.989 0.981 0.970 0.956
    成像时间
    (图像帧数)
    24 min
    (44)
    23 min
    (43)
    22 min
    (42)
    21 min
    (41)
    20 min
    (40)
    19 min
    (39)
    18 min
    (38)
    17 min
    (37)
    K1值回归系数 1.005 1.003 1.002 0.999 0.997 0.993 0.989 0.982
    k2值回归系数 0.941 0.924 0.908 0.887 0.865 0.840 0.813 0.783
    下载: 导出CSV

    表  2  17 min(37帧)成像时间图像数据拟合的不同区域11C-AC药代动力学参数与参考标准的差异

    心肌节段 K1 k2
    参考标准 17 min成像时间 RD (%) P 参考标准 17 min成像时间 RD(%) P
    整体 0.762±0.115 0.788±0.116 3.59±1.99 <0.001 0.120±0.024 0.135±0.029 12.39±6.29 <0.001
    LAD 0.771±0.117 0.801±0.119 3.93±1.98 <0.001 0.119±0.024 0.136±0.029 13.79±6.40 <0.001
    RCA 0.776±0.120 0.795±0.119 2.84±1.89 <0.001 0.120±0.025 0.132±0.032 9.74±5.62 <0.001
    LCX 0.744±0.126 0.769±0.125 3.65±2.25 <0.001 0.121±0.024 0.136±0.030 12.32±6.80 <0.001
    LAD、RCA、LCX:同图 211C-AC:同图 1;RD:同图 4
    下载: 导出CSV
  • [1] Lindner O, Sorensen J, Vogt J, et al. Cardiac efficiency and oxygen consumption measured with 11C-acetate PET after long-term cardiac resynchronization therapy[J]. J Nucl Med, 2006, 47: 378-383.
    [2] Sorensen J, Valind S, Andersson LG. Simultaneous quantification of myocardial perfusion, oxidative metabolism, cardiac efficiency and pump function at rest and during supine bicycle exercise using 11C-acetate PET - a pilot study[J]. Clin Physiol Funct Imaging, 2010, 30: 279-284. doi:  10.1111/j.1475-097X.2010.00938.x
    [3] Liu S, Lin X, Shi X, et al. Myocardial tissue and metabolism characterization in men with alcohol consumption by cardiovascular magnetic resonance and 11C-acetate PET/CT[J]. J Cardiovasc Magn R, 2020, 22: 23. doi:  10.1186/s12968-020-00614-2
    [4] Ukkonen H, Knuuti J, Katoh C, et al. Use of [11 C] acetate and [15 O] O2 PET for the assessment of myocardial oxygen utilization in patients with chronic myocardial infarction[J]. Eur J Nucl Med, 2001, 28: 334-339. doi:  10.1007/s002590000444
    [5] Nesterov SV, Turta O, Han C, et al. 11C acetate has excellent reproducibility for quantification of myocardial oxidative metabolism[J]. Eur Heart J Cardiovasc Imaging, 2015, 16: 500-506. doi:  10.1093/ehjci/jeu289
    [6] Torizuka T, Nobezawa S, Momiki S, et al. Short dynamic FDG-PET imaging protocol for patients with lung cancer[J]. Eur J Nucl Med, 2000, 27: 1538-1542. doi:  10.1007/s002590000312
    [7] Visser EP, Kienhorst L, Geus-Oei L, et al. Shortened dynamic FDG-PET protocol to determine the glucose metabolic rate in non-small cell lung carcinoma[C]. 2008 IEEE Nuclear Science Symposium Conference Record. IEEE, 2008: 4455-4458.
    [8] Monden T, Kudomi N, Sasakawa Y, et al. Shortening the duration of [18 F] FDG PET brain examination for diagnosis of brain glioma[J]. Mol Imaging Biol, 2011, 13: 754-758. doi:  10.1007/s11307-010-0384-z
    [9] Liu G, Yu H, Shi D, et al. Short-time total-body dynamic PET imaging performance in quantifying the kinetic metrics of 18F-FDG in healthy volunteers[J]. Eur J Nucl Med Mol Imaging, 2022, 49: 2493-2503. doi:  10.1007/s00259-021-05500-2
    [10] Samimi R, Kamali-Asl A, Geramifar P, et al. Short-duration dynamic FDG PET imaging: optimization and clinical application[J]. Phys Med, 2020, 80: 193-200. doi:  10.1016/j.ejmp.2020.11.004
    [11] Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association[J]. Circulation, 2002, 105: 539-542. doi:  10.1161/hc0402.102975
    [12] 何升级, 刘帅, 张辉, 等. 基于交替方向乘子法(ADMM)直接重建心脏11C-acetate PET动力学参数图[J]. 中国医学影像技术, 2022, 38: 758-763. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXX202205029.htm
    [13] Dimitrakopoulou-Strauss A, Strauss LG, Heichel T, et al. The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions[J]. J Nucl Med, 2002, 43: 510-518.
    [14] Dimitrakopoulou-Strauss A, Strauss LG, Schwarzbach M, et al. Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading[J]. J Nucl Med, 2001, 42: 713-720.
    [15] Rusten E, Rodal J, Revheim ME, et al. Quantitative dynamic (18)FDG-PET and tracer kinetic analysis of soft tissue sarcomas[J]. Acta Oncol, 2013, 52: 1160-1167. doi:  10.3109/0284186X.2012.728713
    [16] Strauss LG, Dimitrakopoulou-Strauss A, Koczan D, et al. 18F-FDG kinetics and gene expression in giant cell tumors[J]. J Nucl Med, 2004, 45: 1528-1535.
    [17] Dimitrakopoulou-Strauss A, Hohenberger P, Pan L, et al. Dynamic PET with FDG in patients with unresectable aggressive fibromatosis: regression-based parametric images and correlation to the FDG kinetics based on a 2-tissue compartment model[J]. Clin Nucl Med, 2012, 37: 943-948. doi:  10.1097/RLU.0b013e31825b1da4
    [18] Humbert O, Lasserre M, Bertaut A, et al. Breast cancer blood flow and metabolism on dual-acquisition (18)F-FDG PET: correlation with tumor phenotype and neoadjuvant chemotherapy response[J]. J Nucl Med, 2018, 59: 1035-1041. doi:  10.2967/jnumed.117.203075
    [19] Ye Q, Wu J, Lu Y, et al. Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static 18F-FDG PET as a function of injected dose[J]. Phys Med Biol, 2018, 63: 175015. doi:  10.1088/1361-6560/aad97f
    [20] Nishiyama Y, Yamamoto Y, Monden T, et al. Diagnostic value of kinetic analysis using dynamic FDG PET in immunocompetent patients with primary CNS lymphoma[J]. Eur J Nucl Med Mol Imaging, 2007, 34: 78-86. doi:  10.1007/s00259-006-0153-z
  • 加载中
图(4) / 表(2)
计量
  • 文章访问数:  1274
  • HTML全文浏览量:  52
  • PDF下载量:  15
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-03-10
  • 录用日期:  2023-04-20
  • 刊出日期:  2023-07-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!